Susan Domchek of the Perelman School of Medicine comments on lifestyle factors that can help prevent cancer.
Perelman School of Medicine
Sarah Mathews of the Perelman School of Medicine comments on a study that could raise patients’ awareness about herbal supplements and medications not regulated by the FDA that are said to help treat menopausal hot flashes.
Albert Maguire of the Perelman School of Medicine talks about testing a gene therapy product to help restore vision.
Susan Domchek of the Perelman School of Medicine talks about how Angelina Jolie’s transparency about testing positive for a BRCA1 mutation has impacted public awareness about the fight against breast cancer.
Jun Mao of the Perelman School of Medicine is featured for studying alternative therapies, including acupuncture, to treat hot flashes.
Michael Platt of the Perelman School of Medicine, the Wharton School and the School of Arts & Sciences comments on the potential benefits of transcranial magnetic stimulation.
Cancer Doesn't Sleep: The Myc Oncogene Disrupts Circadian Rhythm and Metabolism in Cancer Cells, Finds New Penn Study
Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Postdoctoral fellow Brian Altman, PhD, and doctoral student Annie Hsieh, MD, both from the lab of senior author Chi Van Dang, MD, PhD, director of the Abramson Cancer Center, study body clock proteins associated with cancer cells.
Penn Team Pinpoints Immune Changes in Blood of Melanoma Patients on PD-1 Drugs That Put Potential Biomarker within Reach
A simple blood test can detect early markers of “reinvigorated” T cells and track immune responses in metastatic melanoma patients after initial treatment with the anti-PD-1 drug pembrolizumab, researchers from the Abramson Cancer Center of the University of Pennsylvania report in new research being presented at the inaugural CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.